Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Alibaba

Beyond Meat

Canopy Growth

Alibaba, Canopy Growth, Cronos Group and Beyond Meat were our top stock trades for Tuesday. Let's look at the charts.

4 Top Stock Trades for Tuesday: BABA, BYND, CGC, CRON

Canopy Growth and Cronos Group have more cash on hand than most other cannabis companies, but are they buys?

These 2 Pot Stocks Have the Most Cash to Weather the Downturn

The company's quarterly results are more than a little misleading.

Here's Why Cronos Still Isn't a Buy, Despite Posting a Profit and Boasting $1 Billion in Cash

Aurora Cannabis

Aphria

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Altria

While most sectors are struggling amid COVID-19, marijuana is emerging as an underdog.

Did You Give Up Too Soon on Marijuana Stocks?

Bed Bath & Beyond

Plug Power

Penny stocks are risky investments. But, these five penny stocks have realistic pathways to multi-bagger returns.

5 Speculative Penny Stocks Under $5 That Deserve Your Attention in May

British American Tobacco

Anheuser-Busch InBev

Las Vegas Sands

Philip Morris

Constellation Brands

There’s no question Americans are facing unprecedented stresses these days. Data suggests some Americans are relying on vices such as alcohol, tobacco and cannabis to get through the health crisis.

7 Sin Stocks To Buy During The Coronavirus Shutdown

They might want to send a thank-you note to Aurora Cannabis.

Why Canopy Growth, Cronos Group, and OrganiGram Soared Today

With rising revenue and a strong balance sheet, Cronos Group might just be able to stay afloat amid the pandemic.

Cronos Group Could Survive the COVID-19 Storm

One pot stock has nearly tripled, while two others have walloped their shareholders.

$10,000 Invested in Aurora, Canopy, Cronos, and HEXO 3 Years Ago Would Be Worth This Much Today

Imperial Brands PLC

Big Tobacco: Our Quick Picks

HEXO Corp

Tilray Brands

Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability.

Cannabis Stocks See Rising Tide in Short Interest

Can you pick a winner between the two cannabis giants?

Better Marijuana Stock to Buy: Cronos Group or Canopy Growth?

Revenue came in under expectations, while there was a large asterisk next to the net profit line item.

Cronos Group Slides 3% on Q1 Results

Cronos Group Inc. (CRON) CEO Mike Gorenstein on Q1 2020 Results - Earnings Call Transcript

Cronos missed sales expectations and warned the coronavirus has begun to send tremors through its supply chain.

Pot Stock Warns On Write-Downs, Misses On Sales As Coronavirus Hits Business

4 Most Important Things to Know About Cronos Group's Q1 Update

Cronos (CRON) delivered earnings and revenue surprises of 385.71% and -21.68%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Cronos Group (CRON) Beats Q1 Earnings Estimates

Cronos Group Inc. CRON, +0.35% CRON, +0.12% said Friday it had net income of $75.7 million, or 20 cents a share, in the first quarter, down from $313.9 million, or 33 cents a share, in the year-earlier period.

Canadian cannabis company Cronos posts surprise profit but revenue lags estimates

Cash isn't everything when investing in cannabis stocks.

Even With $1.5 Billion in Cash, This Pot Stock Isn't a Buy

The marijuana stock rebound in 2020 has run into a brick wall, but the fundamentals supporting the industry continue to improve.
The post 4 Marijuana Stocks to Buy for the Big 2020 Rebound (Once Coronavirus Fears Fade) appeared first on InvestorPlace.

4 Marijuana Stocks to Buy for the Big 2020 Rebound (Once Coronavirus Fears Fade)

Investors will focus on regular top and bottom-line numbers along with its pipeline progress, when Cronos (CRON) reports Q1 results.

Cronos (CRON) to Report Q1 Earnings: What's in the Offing?

If you thought edibles, vapes, and infused beverages would be an instant game-changer for Canadian pot stocks, think again.

5 Reasons Cannabis 2.0 Sales Will Disappoint in Canada

Even down more than 90%, some cannabis stocks remain pricey.

3 Pot Stocks That Aren't as Cheap as They Appear

GW Pharmaceuticals

Cannabis short sellers got off to a hot start in 2020 after netting nearly $1 billion in profits in 2019.

Cannabis Stock Rally Puts Short Sellers In The Red For 2020

Trulieve Cannabis Corp.

It's rare to find a cannabis company that can stay out of the red. These three have, but are they good buys today?

3 Pot Stocks That Posted Profits in the Past Year

News for Cronos Group Stock (CRON)